Fundraising Fox
Matthew Reber
InvestorPartner at 1315 Capital
Find your path to Matthew
Sign up to see every warm intro you have to Matthew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Matthew. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Matthew Reber joined 1315 Capital as a Partner in 2017, having previously spent nine years at HealthCare Royalty Partners, where he was a Managing Director, along with earlier roles at Accretive LLC, Paul Capital Partners, Oak Hill Capital Partners, J.H. Whitney & Co., and Morgan Stanley. His investing work focuses on the pharma/medtech outsourcing and pharma/medtech product sectors. He holds a BSc in Engineering from Princeton University, an MBA from The Wharton School, and a Master of Biotechnology from the University of Pennsylvania.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Coating PlaceCodisExpericMedivant HealthcarePrimrose BioProScientoReaction BiologySciSafeUSpharmaVerogen
Per the firm's website.
Colleagues at 1315 Capital
Frequently asked questions
- Who is Matthew Reber?
- Matthew Reber joined 1315 Capital as a Partner in 2017, having previously spent nine years at HealthCare Royalty Partners, where he was a Managing Director, along with earlier roles at Accretive LLC, Paul Capital Partners, Oak Hill Capital Partners, J.H. Whitney & Co., and Morgan Stanley. His investing work focuses on the pharma/medtech outsourcing and pharma/medtech product sectors. He holds a BSc in Engineering from Princeton University, an MBA from The Wharton School, and a Master of Biotechnology from the University of Pennsylvania.
- Where does Matthew Reber work?
- Matthew Reber is Partner at 1315 Capital.
- What does Matthew Reber invest in?
- Matthew Reber invests in Biotech, Healthtech, Medical Devices.
- What boards does Matthew Reber sit on?
- Matthew Reber holds tracked board seats at Coating Place, Codis, Experic, Medivant Healthcare, Primrose Bio, ProSciento, Reaction Biology, SciSafe, USpharma, Verogen.
About this profile. Compiled from public sources — 1315 Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights